HIGHLIGHTS
- who: Jin Wu et al. from the National Cancer Institute at Frederick (NIH), United States Sichuan University, China have published the article: A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer, in the Journal: (JOURNAL)
- what: Our results suggest that a novel signature of 12 genes can be used to predict NAC response and predict prognosis in breast cancer.
- how: The results showed that slowing down the cell cycle and decreasing biological processes and metabolic abnormalities are important mechanisms for the survival of chemo-resistant cells. Considering . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.